Physiologically based pharmacokinetic modeling to assess metabolic drug–drug interaction risks and inform the drug label for fedratinib

por Wu, Fan, Krishna, Gopal, Surapaneni, Sekhar
Publicado 2020

In vitro assessment of cytochrome P450 inhibition and induction potential of azacitidine

por Chen, Yong, Liu, Lisa, Laille, Eric, Kumar, Gondi, Surapaneni, Sekhar
Publicado 2010

Pharmacokinetics, metabolism and excretion of [(14)C]-lenalidomide following oral administration in healthy male subjects

por Chen, Nianhang, Wen, Lian, Lau, Henry, Surapaneni, Sekhar, Kumar, Gondi
Publicado 2011

Absorption, metabolism and excretion of [(14)C]pomalidomide in humans following oral administration

por Hoffmann, Matthew, Kasserra, Claudia, Reyes, Josephine, Schafer, Peter, Kosek, Jolanta, Capone, Lori, Parton, Anastasia, Kim-Kang, Heasook, Surapaneni, Sekhar, Kumar, Gondi
Publicado 2012

Disposition, metabolism and mass balance of [(14)C]apremilast following oral administration

por Hoffmann, Matthew, Kumar, Gondi, Schafer, Peter, Cedzik, Dorota, Capone, Lori, Kei-Fong, Lai, Gu, Zheming, Heller, Dennis, Feng, Hao, Surapaneni, Sekhar, Laskin, Oscar, Wu, Anfan
Publicado 2011

Effect of fluconazole on the pharmacokinetics of a single dose of fedratinib in healthy adults

por Chen, Yizhe, Ogasawara, Ken, Wood-Horrall, Rebecca, Thomas, Mark, Thomas, Michael, He, Bing, Liu, Liangang, Xue, Yongjun, Surapaneni, Sekhar, Carayannopoulos, Leonidas N., Zhou, Simon, Palmisano, Maria, Krishna, Gopal
Publicado 2022